Skip to main content
RT @synovialjoints: Doppelgängers are double walkers with similar features. GPA and IgG-RD are doppelgängers. 3 findin

Dr. Antoni Chan synovialjoints

3 years 11 months ago
Doppelgängers are double walkers with similar features. GPA and IgG-RD are doppelgängers. 3 findings in GPA that are not found in IgG4-RD: ◦ Granulomatous inflammation ◦ Necrosis ◦ Neutrophilic infiltration John Stone, Secrets and Pearls #ACR22 @RheumNow https://t.co/F67EhGBcS4
Best of PsA on Day 1
Hear what KOLs are saying about #ACR22. We are featuring Drs: Michele Petri, Peter Nash, Artie Kavanaugh, Jack Cush. Fo

Dr. John Cush RheumNow

3 years 11 months ago
Hear what KOLs are saying about #ACR22. We are featuring Drs: Michele Petri, Peter Nash, Artie Kavanaugh, Jack Cush. Follow us on Twitter and head to https://t.co/V10S4oVFsv! https://t.co/uRZLffesrq
RT @DrTrishHarkins: Delighted to have caught up with ⁦@SattuiSEMD⁩ to discuss his Abst #0444- Frailty and it’s ass

Patricia Harkins DrTrishHarkins

3 years 11 months ago
Delighted to have caught up with ⁦@SattuiSEMD⁩ to discuss his Abst #0444- Frailty and it’s associated factors in vasculitis #ACR22 ⁦@RheumNow⁩ https://t.co/r2740kuQET
RT @synovialjoints: Treating the underlying CTD is key to managing ILD in combination with anti-fibrotic. In the SENCIS

Dr. Antoni Chan synovialjoints

3 years 11 months ago
Treating the underlying CTD is key to managing ILD in combination with anti-fibrotic. In the SENCIS study, patients on combination of MMF at baseline +Nintedanib had reduced decline in FVC compared to Nintedanib alone https://t.co/NmVRZ44JGE Paul Noble #ACR22 @RheumNow https://t.co/mulaBK61ga
PsA Cycling or Switching MOAs
The RheumNow faculty reporters have been scouring the meeting and online presentations to find the best abstracts from ACR22. Here are some of their choice abstracts reported today on day 1 of ACR 2022 (#ACRbest).  
Join us for our daily topic panels--we'll be live on Twitter, LinkedIn, FB and YouTube OR sign up directly below.

https

Dr. John Cush RheumNow

3 years 11 months ago
Join us for our daily topic panels--we'll be live on Twitter, LinkedIn, FB and YouTube OR sign up directly below. https://t.co/lZK8vsySiD https://t.co/smUveqf3C6
It’s widely accepted that Psoriatic disease has multi-system, multi-domain potential that can lead to life altering complications if left untreated or undertreated. Rheumatologists have shifted the way we discuss treatment options and disease state expectations with patients. Two #ACR22 abstracts stood out to me regarding the Psoriatic disease patient experience and will, ultimately, add to what I do in clinic. 
RT @DrCassySims: What if my #myositis patient gets pregnant?

Abstract #0952 #ACR22 @RheumNow

🫁10 pregnancies ➡ï

Catherine Sims, MD DrCassySims

3 years 11 months ago
What if my #myositis patient gets pregnant? Abstract #0952 #ACR22 @RheumNow 🫁10 pregnancies ➡️ 1 miscarriage -2 preterm -3 low birth wght -1 HELLP -Mean gestational age 36w 🫁 Higher disease activity ➡️ more adverse pregnancy outcomes
RT @uptoTate: Application of 2022 adult-based AAV ACR/EULAR classification criteria to a large cohort of pediatric vascu

Dr. Rachel Tate uptoTate

3 years 11 months ago
Application of 2022 adult-based AAV ACR/EULAR classification criteria to a large cohort of pediatric vasculitis patients resulted in different classification of one-third of patients compared to the EMA classification algorithm. Abs 0456 #ACR22 @RheumNow https://t.co/AWk4RijJLP https://t.co/nX96xTf7KW
×